Cargando…

Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines

Cell lines recapitulating physiological processes can represent alternatives to animal or human studies. The 3T3-L1 cell line is used to mimic adipocyte function and differentiation. Since transfection of 3T3-L1 cells is difficult, we used a modified 3T3-L1 cell line overexpressing Cas9 for a straig...

Descripción completa

Detalles Bibliográficos
Autores principales: Suchý, Tomás, Kaczmarek, Isabell, Maricic, Tomislav, Zieschang, Christian, Schöneberg, Torsten, Thor, Doreen, Liebscher, Ines
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735834/
https://www.ncbi.nlm.nih.gov/pubmed/34915813
http://dx.doi.org/10.1080/21623945.2021.1990480
_version_ 1784628329264971776
author Suchý, Tomás
Kaczmarek, Isabell
Maricic, Tomislav
Zieschang, Christian
Schöneberg, Torsten
Thor, Doreen
Liebscher, Ines
author_facet Suchý, Tomás
Kaczmarek, Isabell
Maricic, Tomislav
Zieschang, Christian
Schöneberg, Torsten
Thor, Doreen
Liebscher, Ines
author_sort Suchý, Tomás
collection PubMed
description Cell lines recapitulating physiological processes can represent alternatives to animal or human studies. The 3T3-L1 cell line is used to mimic adipocyte function and differentiation. Since transfection of 3T3-L1 cells is difficult, we used a modified 3T3-L1 cell line overexpressing Cas9 for a straightforward generation of gene knock-outs. As an example, we intended to generate 3T3-L1 cell lines deficient for adhesion G protein-coupled receptors Gpr64/Adgr2 and Gpr126/Adgr6 using the CRISPR/Cas approach. Surprisingly, all the generated knock-out as well as scramble control cell lines were unresponsive to isoprenaline in respect to adiponectin secretion and lipolysis in contrast to the wild type 3T3-L1 cells. We, therefore, analysed the properties of these stable Cas9-overexpressing 3T3-L1 cells. We demonstrate that this commercially available cell line exhibits dysfunction in cAMP signalling pathways as well as reduced insulin sensitivity independent of gRNA transfection. We tried transient transfection of plasmids harbouring Cas9 as well as direct introduction of the Cas9 protein as alternate approaches to the stable expression of this enzyme. We find that transfection of the Cas9 protein is not only feasible but also does not impair adipogenesis and, therefore, represents a preferable alternative to achieve genetic knock-out.
format Online
Article
Text
id pubmed-8735834
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-87358342022-01-07 Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines Suchý, Tomás Kaczmarek, Isabell Maricic, Tomislav Zieschang, Christian Schöneberg, Torsten Thor, Doreen Liebscher, Ines Adipocyte Technical Reports Cell lines recapitulating physiological processes can represent alternatives to animal or human studies. The 3T3-L1 cell line is used to mimic adipocyte function and differentiation. Since transfection of 3T3-L1 cells is difficult, we used a modified 3T3-L1 cell line overexpressing Cas9 for a straightforward generation of gene knock-outs. As an example, we intended to generate 3T3-L1 cell lines deficient for adhesion G protein-coupled receptors Gpr64/Adgr2 and Gpr126/Adgr6 using the CRISPR/Cas approach. Surprisingly, all the generated knock-out as well as scramble control cell lines were unresponsive to isoprenaline in respect to adiponectin secretion and lipolysis in contrast to the wild type 3T3-L1 cells. We, therefore, analysed the properties of these stable Cas9-overexpressing 3T3-L1 cells. We demonstrate that this commercially available cell line exhibits dysfunction in cAMP signalling pathways as well as reduced insulin sensitivity independent of gRNA transfection. We tried transient transfection of plasmids harbouring Cas9 as well as direct introduction of the Cas9 protein as alternate approaches to the stable expression of this enzyme. We find that transfection of the Cas9 protein is not only feasible but also does not impair adipogenesis and, therefore, represents a preferable alternative to achieve genetic knock-out. Taylor & Francis 2021-12-16 /pmc/articles/PMC8735834/ /pubmed/34915813 http://dx.doi.org/10.1080/21623945.2021.1990480 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Reports
Suchý, Tomás
Kaczmarek, Isabell
Maricic, Tomislav
Zieschang, Christian
Schöneberg, Torsten
Thor, Doreen
Liebscher, Ines
Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines
title Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines
title_full Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines
title_fullStr Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines
title_full_unstemmed Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines
title_short Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines
title_sort evaluating the feasibility of cas9 overexpression in 3t3-l1 cells for generation of genetic knock-out adipocyte cell lines
topic Technical Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735834/
https://www.ncbi.nlm.nih.gov/pubmed/34915813
http://dx.doi.org/10.1080/21623945.2021.1990480
work_keys_str_mv AT suchytomas evaluatingthefeasibilityofcas9overexpressionin3t3l1cellsforgenerationofgeneticknockoutadipocytecelllines
AT kaczmarekisabell evaluatingthefeasibilityofcas9overexpressionin3t3l1cellsforgenerationofgeneticknockoutadipocytecelllines
AT maricictomislav evaluatingthefeasibilityofcas9overexpressionin3t3l1cellsforgenerationofgeneticknockoutadipocytecelllines
AT zieschangchristian evaluatingthefeasibilityofcas9overexpressionin3t3l1cellsforgenerationofgeneticknockoutadipocytecelllines
AT schonebergtorsten evaluatingthefeasibilityofcas9overexpressionin3t3l1cellsforgenerationofgeneticknockoutadipocytecelllines
AT thordoreen evaluatingthefeasibilityofcas9overexpressionin3t3l1cellsforgenerationofgeneticknockoutadipocytecelllines
AT liebscherines evaluatingthefeasibilityofcas9overexpressionin3t3l1cellsforgenerationofgeneticknockoutadipocytecelllines